A new study by researchers from Harvard TH Chan School of Public Health suggests that outpatient prescribing of penicillins is associated with rates of mortality with sepsis in older US adults.
The United Kingdom's Food Standards Agency (FSA) released two surveillance reports this week on antimicrobial resistance (AMR) in chicken meat.
The United Kingdom yesterday announced the launch of a partnership with Nigeria, worth £10.7 million, to fight antimicrobial resistance (AMR) by improving public health surveillance, upgrading laboratory equipment, and training technicians.
CARB-X today announced an award of up to $6.8 million to Pattern Bioscience of Austin, Texas, to develop a rapid identification and antimicrobial susceptibility test (ID/AST) for drug-resistant pathogens.
Imperial College London announced yesterday that it has won a €22.5 million ($25 million US) grant to work with researchers in 15 countries over 5 years to develop a rapid test to diagnose infectious diseases based on personalized gene signatures after taking the next 2 years to develop a library of gene signatures covering common infections and other diseases.
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded $1.5 million to Phase Genomics of Seattle, Washington, to develop a low-cost, culture-free platform for detecting antimicrobial resistance (AMR) genes.
Yesterday, French diagnostics company bioMerieux announced that that the Fleming Fund has selected it as a supplier in a tender process to tackle antimicrobial resistance (AMR) in 18 low- and middle-income countries.
New research by a team of scientists from the United Kingdom suggests that whole-genome sequencing (WGS) should be considered as an alternative to traditional phenotypic testing for national surveillance of antibiotic resistance.
Global funding has reached an all-time high but falls far short of what's needed to eliminate TB.
The US Food and Drug Administration (FDA) today approved a new test to diagnose methicillin-resistant Staphylococcus aureus (MRSA), which will allow health workers to screen patients for MRSA colonization more quickly—in as little as 5 hours compared with 24 to 48 hours for traditional culture-based tests.
